Medical Liaisons in Europe: Competitive Benchmarking of 10 Leading Pharmaceutical Companies' Strategies for Leveraging the Function (2006 Report)
IN-PROGRESS
This study analyzes how leading pharmaceutical companies utilize the medical liaison function to shape medical opinions of their brands in France, Germany, Italy, Spain and the United Kingdom.
In the United States, large forces of field-based liaisons perform a broad range of functions ranging from laying the groundwork for product launches to providing off-label prescribing data to physicians. The European approach has traditionally been to allow a medical director, hospital representatives, or even a business unit director to perform most of these tasks. Now, however, some companies in Europe are implementing field-based approaches that more closely resemble the U.S. model.
The study provides the following information about each target company:
 | Strategic approach to the medical liaison function |
| Organizational structure/reporting relationships by title |
| Distribution of personnel by business unit/therapeutic area |
| Key roles, responsibilities and common backgrounds by title |
| Quantitative and qualitative methods for valuing the function |
| Typical salary range/incentive package by title |
| Evaluation methods |
For clients interested in this same type of information on a global scale, this program is also offered in the United States.
* Save 5% -- Mention "PharmCast.com" when purchase.
To receive more information about the study, including a list of companies analyzed and sample pages, click on the "Request for Info" link.
 |
 |
| [
Outsourcing Guide
] [
Cont. Education
] [
Software/Reports
] [
Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ] [ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ] [ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ] [ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ] |